| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | EXEL | Common Stock | Award | $0 | +63.4K | +17.19% | $0.00 | 432K | Feb 23, 2024 | Direct | F1, F2, F3 |
| transaction | EXEL | Common Stock | Sale | -$1.01M | -47K | -10.89% | $21.45 | 385K | Feb 23, 2024 | Direct | F3, F4 |
| holding | EXEL | Common Stock | 23.5K | Feb 23, 2024 | By spouse | ||||||
| holding | EXEL | Common Stock | 10.6K | Feb 23, 2024 | By 401(k) | F5 |
| Id | Content |
|---|---|
| F1 | Represents shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. Each restricted stock unit is the economic equivalent of one share of Exelixis, Inc. common stock. |
| F2 | The restricted stock units were granted to the Reporting Person on the Transaction Date pursuant to the Exelixis, Inc. 2017 Equity Incentive Plan. The restricted stock units will vest as to 1/4th of the original number of shares subject to the restricted stock unit award on May 15, 2025 and thereafter as to 1/4th of the original number of shares subject to the restricted stock unit award on each May 15th until fully vested. |
| F3 | Includes 300,823 shares of Exelixis, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
| F4 | Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $21.44 to $21.48. Reporting Person undertakes to provide Exelixis, Inc., any security holder of Exelixis, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4. |
| F5 | Represents shares of Exelixis, Inc. common stock under the Exelixis, Inc. 401(k) Plan, pursuant to a plan statement dated as of February 22, 2024. |